Sep 30, 2018

ANI Pharmaceuticals Q3 2018 Earnings Report

Total Revenue
$50.7M
Previous year: $48.2M
+5.3%
EPS
$1.29
Previous year: $1.11
+16.2%
Gross Profit
$35.1M
Previous year: $27.1M
+29.6%
Cash and Equivalents
$44.1M
Previous year: $18M
+144.8%
Free Cash Flow
$6.95M
Previous year: $14.6M
-52.4%
Total Assets
$439M
Previous year: $370M
+18.6%

ANI Pharmaceuticals

ANI Pharmaceuticals